Global Cytology and HPV Testing Market is Expected to Exceed More Than US$ 10 Billion By 2024

In this report, the global cytology and HPV testing market is segmented by product and services and region. On the basis of product and services, the market is segmented into HPV testing and cytology testing. The HPV testing and cytology testing segments are each subdivided into services, assay kits, and system.

The global cytology and HPV testing market is expected to exceed more than US$ 10 billion by 2024. The HPV testing market is projected to register a CAGR of more than 10% during the forecast period. The cytology testing market is projected to register a CAGR of around 5% between 2016 and 2024.

A glimpse of the report structure is provided in the report description available on the website.
https://www.marketresearchengine.com/reportdetails/cytology-and-hpv-testing-market-report

The rising incidence of cervical cancer worldwide, the high occurrence rate of HPV infections, and increasing cervical cancer screening awareness programs are driving the market. However, the lack of appropriate primary healthcare infrastructure and low awareness of the global population are expected to hinder the growth of the market.

The Cytology and HPV testing Market has been segmented as below:


By Product and Services Analysis
HPV Testing
Services
Assay kits
System
Cytology Testing
Services
Assay kits
System


By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World

Becton, Dickinson and Company, Cepheid, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Fujirebio Diagnostics, Inc., Arbor Vita Corporation, Hologic, Inc., QIAGEN N.V., and OncoHealth Corporation are the most active players in the cytology and HPV testing market.

This report covers the cytology and HPV testing market, in terms of value, and forecasts the market size till 2024. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.

Request Free Sample Report:
https://www.marketresearchengine.com/reportdetails/cytology-and-hpv-testing-market-report

This deep-dive study on the cytology and HPV testing market will help customers with the identification of new market opportunities and targeted promotional plans.

Table of Contents

Chapter 1 INTRODUCTION
Chapter 2 Executive Summary
Chapter 3 Cytology and HPV Testing Market – Market Analysis
Chapter 4 Market Segmentation – By Region
Chapter 5 Company Profiles
5.1 Abbott Laboratories, Inc.
5.2 Arbor Vita Corporation
5.3 Becton, Dickinson and Company
5.4 Cepheid, Inc.
5.5 F. Hoffmann-La Roche Ltd.
5.6 Fujirebio Diagnostics, Inc.
5.7 Hologic, Inc.
5.8 OncoHealth Corporation
5.9 QIAGEN N.V

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.